Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Globavir
Globavir is a developer of therapeutics and diagnostics for the treatment of global infectious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
AltPep
AltPep is a biomedical startup revolutionizing the diagnosis and treatment of amyloid diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company that develops novel drugs to treat neurodegenerative diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
AsclepiX Therapeutics
AsclepiX Therapeutics is a biotech company that develops novel therapeutics for retinal diseases and cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Otsuka Pharmaceutical
announced date
price
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 05.10.2017. Their latest investor Merck Research Laboratories. Their latest round Series C
Alexandria Venture Investments
Alexandria Venture Investments is a venture capital firm that invests in real estate technology and healthcare sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Polaris Partners
Polaris Partners is a venture capital firm that invests in healthcare and technology companies at all stages of growth.
Sector
Subsector
Location
count Of Investments
count Of Exists
MRL Ventures Fund
Merck's MRL Ventures is investing in breakthrough science to develop new medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is a philanthropic organization.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Flagship Pioneering
Flagship Pioneering creates and grows ventures to transform health and sustainability.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors14
Number of lead investors
Number of investors
Merck Research Laboratories
Merck Research Laboratories discovers and develops medicines for cancer and neurodegenerative disorders.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Alexandria Venture Investments
Alexandria Venture Investments is a venture capital firm that invests in real estate technology and healthcare sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Vertex Ventures HC
Vertex Ventures HC is a venture capital company that invests in healthcare startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Kevin Bitterman
Kevin is the interim president of Editas Medicine and a principal at Polaris Partners. He joined Polaris in 2004 and focuses on investments in health care. Kevin is a co-founder of Genocea Biosciences and Sirtris Pharmaceuticals (acquired by GSK) and was the founding CEO at Visterra Inc. (formerly Parasol Therapeutics). He currently represents Polaris as a director of InSeal Medical, Genocea Biosciences, Kala Pharmaceuticals, Neuronetics, Inc., Visterra Inc., Taris Biomedical and Vets First Choice. Additionally, he is a board observer to Arsenal Medical and 480 Biomedical.Kevin holds a Ph.D. in genetics from Harvard Medical School. His doctoral research focused on the molecular regulation of caloric restriction and on modulation of a novel class of protein deacetylases.
current job
Kevin Bitterman
Employee Profiles24
Taizo Yoshida
Associate director, strategic planning and corporate development at visterra inc